BIOMAT Database Logo BIOMAT Database Logo

Multicentre pilot study for therapy of acute lymphoblastic and acute undifferentiated leukemia in adults. 1983

D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults.
February 1991, Current opinion in oncology,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Therapy of acute lymphoblastic leukemia in adults.
January 1992, Leukemia,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Induction therapy for adults with acute lymphoblastic leukemia.
November 2006, Current oncology reports,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults.
May 2011, Nature reviews. Clinical oncology,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia.
April 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
[The programmed therapy of acute lymphoblastic leukemia in adults].
January 1992, Terapevticheskii arkhiv,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
[Acute undifferentiated leukemia--acute lymphocytic leukemia of adults. Differential diagnosis, prognosis, results of therapy].
August 1974, Medizinische Klinik,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Therapy Options in Treating Acute Lymphoblastic Leukemia in Adults.
July 2019, Oncology (Williston Park, N.Y.),
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Acute lymphoblastic leukemia in adults.
April 2000, Current treatment options in oncology,
D Hoelzer, and E Thiel, and H Löffler, and H Bodenstein, and T Büchner, and D Messerer
Acute lymphoblastic leukemia in adults.
June 1985, Seminars in oncology,
Copied contents to your clipboard!